SCHEMBL25807900

SCHEMBL25807900

CC[C@H]1O[C@@H](n2ccc(=O)c3nccn32)[C@H](O[Si](C(C)C)(C(C)C)C(C)C)[C@@H]1O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25807895 0.83 ADK (0.40) ADK
SCHEMBL22577556 0.81 — —
SCHEMBL22577531 0.80 TYMP (0.48) —
SCHEMBL25807902 0.79 MAPT (0.33) ADK
SCHEMBL22577582 0.75 TYMP (0.47) —
SCHEMBL22577499 0.73 MAPT (0.51) —
SCHEMBL16016758 0.71 SLC28A1 (0.52) —
SCHEMBL14418621 0.71 LMNA (0.40) —
SCHEMBL16016760 0.71 SLC28A1 (0.52) —
SCHEMBL22577542 0.70 TYMP (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists MERCK SHARP & DOHME LLC (US) 2023-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685761-B2 Cyclic di-nucleotide compounds as sting agonists STING1, CGAS, IFNAR1 ADK 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback